Christine Alewine
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Christine Alewine | |
---|---|
Born | Christine K. Campo |
Alma mater | Dartmouth College (BA) University of Maryland School of Medicine (MD, PhD) |
Children | 2 |
Scientific career | |
Fields | Oncology, biology |
Institutions | National Cancer Institute |
Thesis | PDZ protein regulation of Kir 2.3 (2006) |
Christine Campo Alewine is an American oncologist and biologist researching immunotoxin therapeutics in pancreatic cancer. She is an investigator at the National Cancer Institute.
Education
Campo completed a B.A. in chemistry and
medical oncology at NCI.[2]
Career and research
She joined NCI's laboratory of molecular biology as an assistant clinical investigator through the support of the clinical investigator development program in 2014 and became a tenure-track investigator through the
tumor cells, including pancreatic, ovarian, and some lung cancers.[5]
Personal life
Alewine is married with two daughters.[1]
References
- ^ a b "Lasker Clinical Research Scholars". NIH Intramural Research Program. 2017-02-27. Retrieved 2020-07-21. This article incorporates text from this source, which is in the public domain.
- ^ a b c "Principal Investigators". NIH Intramural Research Program. Retrieved 2020-07-21. This article incorporates text from this source, which is in the public domain.
- OCLC 77637455.
- ^ "Christine Campo Alewine, M.D., Ph.D." Center for Cancer Research. 2014-08-12. Retrieved 2020-07-21. This article incorporates text from this source, which is in the public domain.
- ^ "Dr. Christine Alewine — Treating Pancreatic Cancer with New Immunotoxin Strategies". NIH Intramural Research Program. 2019-02-04. Retrieved 2020-07-21. This article incorporates text from this source, which is in the public domain.
External links
- Christine Alewine's publications indexed by the Scopus bibliographic database. (subscription required)